Get started Log in

IMM — ImmuPharma Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

UK's ImmuPharma rises as USFDA sets Type-C meeting date for lupus treatment
19/04/2023 08:25
Brief: ImmuPharma Says USFDA Confirms Type-C Meeting Date For Lupuzor
19/04/2023 07:27
Lupozor Update - FDA confirms Type-C meeting date
19/04/2023 07:00
UK's ImmuPharma gains on progress in new autoimmune treatment development
12/04/2023 08:39
Brief: ImmuPharma PLC Provides CIDP P140 Clinical Program Update
12/04/2023 07:35
CIDP P140 Clinical Program Update
12/04/2023 07:00
UK's ImmuPharma gains on submission of trial protocol for lupus treatment
27/03/2023 09:32
Brief: ImmuPharma Provides Lupuzor™ Update
27/03/2023 08:24
Lupuzor™ Update
27/03/2023 07:00
UK's ImmuPharma gains on collaboration with Orano for cancer treatment
06/03/2023 09:48
Brief: ImmuPharma Announces Collaboration With Orano On Its Peptide Technology
06/03/2023 07:27
Collaboration with Orano on ImmuPharma Peptide
06/03/2023 07:00
UK's ImmuPharma jumps on clinical trial agreement for lupus study
06/02/2023 08:45
Brief: Immupharma Agrees With Avion For Phase 2/3 Adaptive Study Design For Lupus Study
06/02/2023 07:36
Lupuzor™ Update
06/02/2023 07:00
TR-1: Notification of major holdings
27/01/2023 16:25
TR-1: Notification of major holdings
04/01/2023 17:26
Second Price Monitoring Extn
04/01/2023 16:40
Price Monitoring Extension
04/01/2023 16:35
TR-1: Notification of major holdings
03/01/2023 16:58